Top Pharma Stocks

This stock forecast is designed for investors and analysts who need predictions of the best stocks for the whole Pharmaceutical sector (see Pharma Stocks Package). It includes 20 stocks with bullish and bearish signals and indicates the best pharmaceutical stocks to trade:

• Top 10 Pharmaceutical stocks for the long position
• Top 10 Pharmaceutical stocks for the short position

Package Name: Pharma Stocks Forecast
Recommended Positions: Long
Forecast Length: 14 Days (4/7/2020 – 4/21/2020)
I Know First Average: 11.17%

For this 14 Days forecast the algorithm had successfully predicted 9 out of 10 movements. The greatest return came from LGND at 24.43%. ALNY and FOLD also performed well for this time horizon with returns of 22.93% and 21.29%, respectively. With these notable trade returns, the package itself registered an average return of 11.17% compared to the S&P 500’s return of 2.74% for the same period.

Ligand Pharmaceuticals Incorporated (Ligand), incorporated on September 28, 1987, is a biopharmaceutical company that focuses on developing and acquiring technologies that help pharmaceutical companies discover and develop medicines. The Company is involved in the development and licensing of biopharmaceutical assets. The Company employs research technologies, such as nuclear receptor assays, high throughput computer screening, formulation science, liver targeted pro-drug technologies and antibody discovery technologies to assist companies in their work towards obtaining prescription drug approvals. As of December 31, 2016, it had partnerships and license agreements with over 85 pharmaceutical and biotechnology companies, and over 140 various programs under license with it were in various stages of commercialization and development. It has contributed research and technologies for approved medicines that treat cancer, osteoporosis, fungal infections and low blood platelets, among others. Its partners have programs in clinical development targeting seizure, coma, cancer, diabetes, cardiovascular disease, muscle wasting, liver disease and kidney disease, among others. The Company is developing a small molecule glucagon receptor antagonist for the treatment of Type II diabetes mellitus.

Algorithmic traders utilize these daily forecasts by the I Know First market prediction system as a tool to enhance portfolio performance, verify their own analysis and act on market opportunities faster. This forecast was sent to current I Know First subscribers.

How to interpret this diagram

Algorithmic Stock Forecast: The table on the left is a stock forecast produced by I Know First’s algorithm. Each day, subscribers receive forecasts for six different time horizons. Note that the top 10 stocks in the 1-month forecast may be different than those in the 1-year forecast. In the included table, only the relevant stocks have been included. The boxes are arranged according to their respective signal and predictability values (see below for detailed definitions). A green box represents a positive forecast, suggesting a long position, while a red represents a negative forecast, suggesting a short position.

Please note-for trading decisions use the most recent forecast. Get today’s forecast and Top stock picks.